Valion Bio Raises $4.72 Million in Private Placement

Valion Bio entered into two side letters on October 26, 2026, for sales of preferred stock and warrants. The Series B transaction with 3i has an aggregate purchase price of $50,000, while the Series C transaction totals $4,717,717.61, including $1.5 million in new cash and $3,217,717.61 applied to…